On Tuesday, Geron Corp. (NASDAQ: GERN) opened higher 2.00% from the last session, before settling in for the closing price of $4.51. Price fluctuations for GERN have ranged from $1.64 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 46.26% over the last five years. Company’s average yearly earnings per share was noted -10.21% at the time writing. With a float of $500.46 million, this company’s outstanding shares have now reached $544.91 million.
The firm has a total of 141 workers. Let’s measure their productivity.
Geron Corp. (GERN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp. is 15.62%, while institutional ownership is 58.43%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Corp Strategy & CCO sold 421,875 for $4.64, making the entire transaction worth $1,959,609. This insider now owns 0 shares in total.
Geron Corp. (GERN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -10.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp. (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp. (GERN). In the past quarter, the stock posted a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5246.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Geron Corp. (GERN)
Analysing the last 5-days average volume posted by the [Geron Corp., GERN], we can find that recorded value of 12.43 million was better than the volume posted last year of 11.38 million. As of the previous 9 days, the stock’s Stochastic %D was 54.36%. Additionally, its Average True Range was 0.24.
During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 80.00%, which indicates a significant increase from 60.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.84% in the past 14 days, which was lower than the 119.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.45, while its 200-day Moving Average is $3.00. Now, the first resistance to watch is $4.70. This is followed by the second major resistance level at $4.81. The third major resistance level sits at $4.92. If the price goes on to break the first support level at $4.48, it is likely to go to the next support level at $4.37. Now, if the price goes above the second support level, the third support stands at $4.26.
Geron Corp. (NASDAQ: GERN) Key Stats
There are currently 593,133K shares outstanding in the company with a market cap of 2.73 billion. Presently, the company’s annual sales total 240 K according to its annual income of -184,130 K. Last quarter, the company’s sales amounted to 300 K and its income totaled -55,390 K.
